Bengaluru, July 22 -- The share of this company, which is a leading Indian contract research, development, and manufacturing organization, came under pressure after the company reported weak Q1 numbers

With a market capitalization of Rs 43,304 crore, Anthem Biosciences Ltd's share on Wednesday made a day low of Rs 735 per share, down by 7.1 percent from its previous close price of Rs 791.70 per share. The share of this company has given 5.42 percent over the last year.

Result Overview

QoQ View

The revenue from operations declined by 31.5 percent QoQ to Rs 418.2 crore in Q1 FY27 from Rs 610.9 crore in Q4 FY26. EBITDA fell by 44.9 percent QoQ to Rs 175.5 crore from Rs 318.4 crore, while the EBITDA margin declined to 39.6 percent from 52...